Related Experiment Video
Updated: Apr 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Genetic diagnosis for a Chinese Han family with primary hypertrophic osteoarthropathy]
1Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China. zhaoyunzhang@fudan.edu.cn; xpliu1228@fudan.edu.cn.
Objective:
To identify the genetic cause for a Chinese Han family affected with primary hypertrophic osteoarthropathy.
Methods:
Whole blood and urine samples were collected from a patient and 7 unaffected relatives of the family. The coding sequences and intron/exon boundaries of HPGD and SLCO2A1 genes of the patient were amplified with polymerase chain reaction and sequenced. The genotypes of relatives were subsequently verified. Urinary prostaglandin level was measured with enzyme-linked immunosorbent assay (ELISA).
Results:
A homozygous 2-bp deletion in HPGD gene (c.310_311delCT, or p.L104AfsX3) was detected in the patient, and 5 heterozygous carriers were identified in the relatives. The urinary prostaglandin E2 (PGE2) level was significantly elevated (P<0.01), while PGE-M was significantly reduced (P<0.01) in the patient.
Conclusion:
Primary hypertrophic osteoarthropathy in this family is caused by a homozygous mutation (c.310_311delCT) in the HPGD gene.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Lingo
Incomplete Dominance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Animal Mitochondrial Genetics
Pedigree Analysis

